Zhen Li
Fortune : 117 M $ au 30/09/2026
Fortune : 117 M $ au 30/09/2026
Dr. Zhen Li is a President, Chief Executive Officer & Director at ADARx Pharmaceuticals, Inc. She is on the Board of Directors at ADARx Pharmaceuticals, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/09/2026 | 5 861 199 ( 5,49 % ) | 117 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Fondateur | 01/12/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Directeur/Membre du Conseil | - |
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA therapeutics to treat diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national